LA

Lavo Life Sciences

YC W23 ↗

Founded 2022 · 3 employees · Inactive · 3 known investors

lavo.ai ↗

Lavo Life Sciences offers computational molecular simulations to pharmaceutical companies, helping them optimize drug formulations, reduce experimental costs, and accelerate the path to clinical trials and regulatory approval.

Founders & leadership· Y Combinator alumni (W23)

SS

Scott SwarthoutinFounder

ZG

Zach GlickinFounder

DM

Derek Metcalfin𝕏Founder

Investors · 3

EA

Eastlink Capital PartnersMenlo Park · $100K – $5M

UN

Undeterred CapitalLos Angeles · $500K – $1Mvia Joe Wilson · inferred

Y

Y CombinatorSan Francisco · $500K